title: Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease.
abstract: We measured the CSF levels of 21, and the plasma levels of 26, amino acids in 31 patients with Parkinson's disease (PD) and in 45 matched controls. We used an ion-exchange chromatography method. When compared to controls, PD patients had lower CSF levels of taurine, alanine, valine, leucine, isoleucine, ethanolamine, citrulline, ornithine, lysine, histidine, arginine, and alpha-aminobutyric acid. PD patients not treated with levodopa or with dopamine agonists had higher CSF tyrosine and phenylalanine levels than those not treated with these drugs and also than controls. PD patients had higher plasma levels of phosphoserine, threonine, methionine, tyrosine, sarcosine and alpha-aminoadipic acid, and lower plasma levels of valine, leucine, and tryptophan, than controls. The CSF/plasma ratio of many of these amino acids was significantly lower in PD patients than those of controls, suggesting that PD patients might have a dysfunction in the transport of neutral and basic amino acids across the blood-brain barrier.
authors.affiliation: Department of Neurology, Hospital Doce de Octubre, Madrid, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Molina
authors.forename: F J
authors.initials: FJ
authors.lastname: Jiménez-Jiménez
authors.forename: P
authors.initials: P
authors.lastname: Gomez
authors.forename: C
authors.initials: C
authors.lastname: Vargas
authors.forename: J A
authors.initials: JA
authors.lastname: Navarro
authors.forename: M
authors.initials: M
authors.lastname: Ortí-Pareja
authors.forename: T
authors.initials: T
authors.lastname: Gasalla
authors.forename: J
authors.initials: J
authors.lastname: Benito-León
authors.forename: F
authors.initials: F
authors.lastname: Bermejo
authors.forename: J
authors.initials: J
authors.lastname: Arenas
mesh_terms: D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000134:cerebrospinal fluid* / Q000145:classification; D000978:Antiparkinson Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D012016:Reference Values
chemical_list: D000596:Amino Acids; D000978:Antiparkinson Agents